Related Articles
MicroRNA‑25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a
BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells
ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines
Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin
Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway